Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Vorinostat × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 7 Breast Neoplasms 4 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Multiple Myeloma 2 Mesothelioma 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Stomach Neoplasms 1 Sezary Syndrome 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

Cisplatin 54 Pemetrexed 43 pembrolizumab 16 Nivolumab 14 Carboplatin 14 Gemcitabine 13 Cyclophosphamide 10 Radiotherapy 9 Drug Therapy 8 atezolizumab 7 Ipilimumab 7 durvalumab 6 Platinum 6 Doxorubicin 6 1,2-diaminocyclohexaneplatinum II citrate 6 tremelimumab 5 sodium thiosulfate 5 Vinorelbine 5 Radiotherapy, Intensity-Modulated 5 Chemotherapy, Adjuvant 5 Cerebral Decortication 5 sargramostim 4 defactinib 4 tumor necrosis factor-alpha, CNGRC fusion protein, human 3 Photochemotherapy 3 Neoadjuvant Therapy 3 Mitomycin 3 Interleukin-2 3 Dihematoporphyrin Ether 3 Decitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01353482 2012-03-22

MESO-02

University College, London

Phase 1/2 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡